McKesson Co. (NYSE:MCK) Stake Lessened by CLARET ASSET MANAGEMENT Corp

Share on StockTwits

CLARET ASSET MANAGEMENT Corp cut its stake in McKesson Co. (NYSE:MCK) by 1.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,755 shares of the company’s stock after selling 533 shares during the period. McKesson makes up approximately 1.3% of CLARET ASSET MANAGEMENT Corp’s investment portfolio, making the stock its 20th biggest position. CLARET ASSET MANAGEMENT Corp’s holdings in McKesson were worth $6,526,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Gradient Investments LLC lifted its stake in McKesson by 1,944.4% during the second quarter. Gradient Investments LLC now owns 184 shares of the company’s stock valued at $25,000 after purchasing an additional 175 shares during the last quarter. Berman Capital Advisors LLC lifted its stake in McKesson by 175.2% during the second quarter. Berman Capital Advisors LLC now owns 289 shares of the company’s stock valued at $37,000 after purchasing an additional 184 shares during the last quarter. CSat Investment Advisory L.P. lifted its stake in McKesson by 165.8% during the second quarter. CSat Investment Advisory L.P. now owns 295 shares of the company’s stock valued at $40,000 after purchasing an additional 184 shares during the last quarter. Prestige Wealth Management Group LLC acquired a new stake in McKesson during the second quarter valued at approximately $42,000. Finally, Asset Dedication LLC lifted its stake in McKesson by 35.2% during the second quarter. Asset Dedication LLC now owns 346 shares of the company’s stock valued at $46,000 after purchasing an additional 90 shares during the last quarter. Institutional investors and hedge funds own 86.62% of the company’s stock.

In other news, Director M Christine Jacobs sold 1,296 shares of the stock in a transaction on Monday, August 5th. The shares were sold at an average price of $146.65, for a total transaction of $190,058.40. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Lori A. Schechter sold 2,500 shares of the stock in a transaction on Monday, September 9th. The stock was sold at an average price of $144.40, for a total transaction of $361,000.00. Following the transaction, the executive vice president now owns 4,535 shares in the company, valued at approximately $654,854. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 10,218 shares of company stock worth $1,421,738. 0.88% of the stock is currently owned by company insiders.

Several equities research analysts recently commented on MCK shares. Guggenheim started coverage on shares of McKesson in a research report on Monday, July 22nd. They issued a “neutral” rating and a $152.00 price target for the company. ValuEngine downgraded shares of McKesson from a “sell” rating to a “strong sell” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. started coverage on shares of McKesson in a research report on Monday, July 22nd. They issued an “overweight” rating and a $164.00 price target for the company. Credit Suisse Group started coverage on shares of McKesson in a research report on Monday, July 22nd. They issued a “neutral” rating and a $143.00 target price for the company. Finally, Morgan Stanley increased their target price on shares of McKesson from $130.00 to $135.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 27th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. McKesson has a consensus rating of “Hold” and an average target price of $147.20.

MCK stock traded up $2.24 during midday trading on Friday, reaching $135.05. The company had a trading volume of 36,377 shares, compared to its average volume of 1,698,545. McKesson Co. has a 1 year low of $106.11 and a 1 year high of $150.82. The company has a current ratio of 1.01, a quick ratio of 0.58 and a debt-to-equity ratio of 1.14. The company has a market capitalization of $24.09 billion, a P/E ratio of 9.95, a PEG ratio of 1.31 and a beta of 1.14. The company has a 50 day moving average of $140.10 and a two-hundred day moving average of $132.51.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, July 31st. The company reported $3.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.04 by $0.27. McKesson had a net margin of 0.27% and a return on equity of 30.73%. The company had revenue of $55.73 billion during the quarter, compared to the consensus estimate of $54.03 billion. During the same quarter in the prior year, the firm earned $2.90 EPS. The company’s revenue was up 5.9% compared to the same quarter last year. On average, sell-side analysts anticipate that McKesson Co. will post 14.39 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Tuesday, September 3rd were paid a dividend of $0.41 per share. This is a positive change from McKesson’s previous quarterly dividend of $0.39. The ex-dividend date was Friday, August 30th. This represents a $1.64 annualized dividend and a dividend yield of 1.21%. McKesson’s dividend payout ratio is 12.09%.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Featured Article: What is a dead cat bounce?

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.